Results 151 to 160 of about 18,660,361 (398)

Multi‐omic characterization of consensus molecular subtype 1 (CMS1) colorectal cancer with dampened immune response improves precision medicine

Molecular Oncology, EarlyView.
This study highlights the importance of multi‐omic analyses in characterizing colorectal cancers. Indeed, our analysis revealed a rare CMS1 exhibiting dampened immune activation, including reduced PD‐1 expression, moderate CD8+ T‐cell infiltration, and suppressed JAK/STAT pathway.
Livia Concetti, Manuel Scimeca, Julia Bischof, Jonathan Woodsmith, Massimiliano Agostini, Cristina Fiorani, Yufang Shi, Eleonora Candi, Gerry Melino, Alessandro Mauriello, Giuseppe S. Sica   +10 more
wiley   +1 more source

Correction: Impact of taxes and warning labels on red meat purchases among US consumers: A randomized controlled trial.

PLoS Medicine
[This corrects the article DOI: 10.1371/journal.pmed.1004284.].
PLOS Medicine Staff
doaj   +1 more source

Forensic Medicine: A text-book for Students and a Guide for Practitioners [PDF]

, 1940

openalex   +1 more source

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

Focusing the spotlight on lack of access to health information. [PDF]

PLoS Medicine, 2013
PLoS Medicine Editors
doaj   +1 more source

Evidence based medicine: what it is and what it isn't

British medical journal, 1996
D. Sackett, W. Rosenberg, James Douglas Allan Gray, Haynes Rb, W. Richardson   +4 more
semanticscholar   +1 more source

An illustrated dictionary of medicine, biology and allied sciences

, 1900
George M. Gould
openalex   +2 more sources

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Ghostwriting revisited: new perspectives but few solutions in sight. [PDF]

PLoS Medicine, 2011
PLoS Medicine Editors
doaj   +1 more source

On Moral Medicine [PDF]

Charles Caldwell
openalex   +1 more source